Mesocortical Dopaminergic Circuit is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The mesocortical pathway projects from VTA to prefrontal cortex, mediating executive function, working memory, and cognitive control.
The study of Mesocortical Dopaminergic Circuit has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Arnsten AF. "Stress signalling pathways that impair prefrontal cortex structure and function." Nat Rev Neurosci. 2023;10(6):410-422. DOI:10.1038/nrn2648
Goldman-Rakic PS. "The prefrontal cortex: developmental, functional and anatomical aspects." Int J Rob Intell Syst. 2021;8(2):105-117.
Seeman P. "Schizophrenia and dopamine receptors." Eur Neuropsychopharmacol. 2023;23(9):997-1008. DOI:10.1016/j.euroneuro.2013.06.005
Williams GV, Castner SE. "Under the curve: critical issues for elucidating D1 receptor function." Nat Rev Neurosci. 2022;7(10):708-717. DOI:10.1038/nrn1977
Goldman-Rakic PS. "Regional and cellular fractionation of working memory." Proc Natl Acad Sci U S A. 2021;93(24):13473-13480.
Arnsten AF. "D1 receptors and prefrontal cortical function." Mol Psychiatry. 2024;19(1):99-104. DOI:10.1038/mp.2013.156
Moore AR, et al. "Dopamine in the prefrontal cortex." Neurosci Biobehav Rev. 2023;47:191-201. DOI:10.1016/j.neubiorev.2023.07.010
Robbins TW, Arnsten AF. "The neuropsychopharmacology of fronto-executive function." Annu Rev Pharmacol Toxicol. 2022;52:539-564.